1. Characteristics of the included interventions: source and channel of information.
| Study (PEM) | Source of information * | Endorsement | Tailoring ¶ | Mode of delivery¥ | Frequency of delivery | Duration of delivery |
| Austin 2003 (HERS trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Austin 2004‐A (WHI trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Austin 2004‐B (ALLHAT trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Austin 2005 | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Avorn 1983 | 2 | unclear | 2 | 3 | 4 times | 4‐6 months |
| Azocar 2003 | 1; 3 | unclear | 1 | 3 | once | once |
| Barbaglia 2009 (WHI trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Bearcroft 1994 | 1 | unclear | 1 | 3 | once | once |
| Beaulieu 2004 | 4 | yes | 3 | 4 | twice | 1‐3 months |
| Bjornson 1990 | 3 | unclear | 1 | 3 | once | once |
| Black 2002 (EHC‐OM bulletin) | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Buyle 2010 | 3 | yes | 4 | 2 | indeterminate | indeterminate |
| Coopersmith 2002 | 6 | unclear | 2 | 7 | once | once |
| Denig 1990 | 5 | yes | 3 | 3 | once | once |
| Dormuth 2004 | 2 | yes | 3 | 4 | 4 times | > 6 months |
| Fijn 2000 | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Fonarow 2009 (MIRACL trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Fonarow 2009 (PROVE‐IT TIMI 22 trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Fonarow 2009 (ACC‐AHA‐STEMI guidelines) | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Fonarow 2009 (AHA‐AHA‐NS guidelines) | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Fukuda 2009 | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Guay 2007 (WHI publication) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Haas 2004 (HERS publication) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Haas 2004 (WHI publication) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Hersh 2004 (WHI; HERS; HERSIII publications) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Jackevicius 2001 | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Jameson 2010 | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Jousimaa 2002 | 4 | unclear | 4 | 3 | once | once |
| Juurlink 2004 | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Kabir 2007 (LIFE publication) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Kabir 2007 (ALLHAT publication) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Kabir 2007 (VALUE trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Kajita 2012 | 9 | unclear | 4 | 3 | once | once |
| Kottke 1989 | 9 | unclear | 4 | 7 | once | once |
| Lam 2009 | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Majumdar 2003 (HOPE trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Majumdar 2003 (RALES trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Majumdar 2004 (WHI trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Mason 1998 | 9 | yes | 4 | 4 | once | once |
| Mason 2001 (EHC‐OM bulletin) | 4 | yes | 4 | 2 | once | once |
| Matowe 2002 | 4 | yes | 4 | 4 | once | once |
| Meyer 2007 | 1; 3 | yes | 4 | 7 | once | once |
| Oakeshott 1994 | 4 | yes | 4 | 4 | once | once |
| Perria 2007 | 1; 3 | unclear | 4 | 3 | once | once |
| Roberts 2007 | 4 | unclear | 4 | 2 | indeterminate | indeterminate |
| Santerre 1996 | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Shah 2008 | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Stafford 2004 (ALLHAT trial report) | 1 | yes | 4 | 1 | indeterminate | indeterminate |
| Tsuji 2009 | 1 | no | 4 | 7 | once | once |
| Wang 2005 (ADA guidelines; ATP III trial report) | 4 | yes | 4 | 2 | indeterminate | indeterminate |
| Watson 2001 | 3 | no | 4 | 3 | once | once |
| Weiss 2011 | 3 | yes | 4 | 4 | once | once |
* Source of information: 1 = researchers / clinicians; 2 = university; 3 = local expert body; 4 = national professional expert body; 5 = national government expert body; 6 = local clinicians; 7 = international professional expert body; 8 = international government expert body; 9 = unclear.
¶ Tailoring: 1 = tailored to individuals based on diagnostic, behavioural, or motivational characteristics; 2 = tailored to groups of individuals; 3 = personalised, but not tailored (person's name on the information); 4 = generic; 5 = unclear.
¥ Mode of delivery: 1 = publication in peer‐reviewed journal; 2 = passive dissemination; 3 = direct mailing; 4 = mass mailing; 5 = media; 6 = hand delivery; 7 = unclear.